Log in to save to my catalogue

EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to...

EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2909084513

EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma

About this item

Full title

EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma

Publisher

India: Wolters Kluwer - Medknow

Journal title

Journal of cancer research and therapeutics, 2023-12, Vol.19 (6), p.1544-1551

Language

English

Formats

Publication information

Publisher

India: Wolters Kluwer - Medknow

More information

Scope and Contents

Contents

Context:
Salinomycin (SAL) is a chemotherapeutic drug with anti-osteosarcoma efficacy, but its hydrophobic properties have hindered its application. Nanoparticles have been widely used as drug carriers to improve the solubility of hydrophobic drugs. The dodecapeptide GE11 has been shown to have great binding affinity to the epidermal growth fact...

Alternative Titles

Full title

EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2909084513

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2909084513

Other Identifiers

ISSN

0973-1482

E-ISSN

1998-4138

DOI

10.4103/jcrt.jcrt_2503_22

How to access this item